|Day Low/High||217.71 / 217.94|
|52 Wk Low/High||65.54 / 217.94|
Conference call and webcast on November 10 at 4:30 p.m. EST
AveXis, Inc. (NASDAQ: AVXS), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today provided an update on interim data from the...
Here's a technical look at how to trade several stocks rising on unusual volume.
Conference call and webcast on August 11 at 4:30 p.m. EDT
An experimental treatment for a rare, children's spine disorder developed by Ionis achieved the primary endpoint of a late-stage clinical trial, triggering Biogen to exercise a partnership option.
Here are Wednesday's top research calls, including downgrades for Domino's Pizza, McDonald's and Tesla, and an upgrade for Priceline.
These stocks are setting up to trigger big breakout trades. Here's how to trade them from here.
Here's the lowdown on the biotech companies that have come public this year.
-- Richard Shell, MD, Presented Data as of April 1, 2016 at the American Thoracic Society 2016 Conference --
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.